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Background: Arginine 85 of NDUFS2, a subunit of mitochondrial complex I, is symmetrically dimethylated.
Results: NDUFAF7, a protein methylase in the matrix of mitochondria, modifies arginine 85 of NDUFS2 during assembly of
complex I.
Conclusion:Methylation of arginine 85 of NDUFS2 is required for assembly of complex I.
Significance: The arginine protein methylase, NDUFAF7, is an assembly factor for human complex I.
Complex I (NADH ubiquinone oxidoreductase) in mamma-
lian mitochondria is an L-shaped assembly of 44 subunits. One
arm is embedded in the innermembranewith theother protrud-
ing 100 Å into the matrix of the organelle. The extrinsic arm
contains binding sites for NADH and the primary electron
acceptor FMN, and it provides a scaffold for seven iron-sulfur
clusters that form an electron pathway linking FMN to the ter-
minal electron acceptor, ubiquinone, which is bound in the
region of the junction between the arms. The membrane arm
contains four antiporter-like domains, probably energetically
coupled to the quinone site and involved in pumping protons
from the matrix into the intermembrane space contributing to
the proton motive force. Complex I is put together from preas-
sembled subcomplexes. Their compositions have been charac-
terized partially, and at least 12 extrinsic assembly factor pro-
teins are required for the assembly of the complex. One such
factor, NDUFAF7, is predicted to belong to the family of S-
adenosylmethionine-dependent methyltransferases character-
ized by the presence in their structures of a seven--strand pro-
tein fold. In the present study, the presence of NDUFAF7 in the
mitochondrial matrix has been confirmed, and it has been
demonstrated that it is a protein methylase that symmetrically
dimethylates the -NG,NG atoms of residue Arg-85 in the
NDUFS2 subunit of complex I. This methylation step occurs
early in the assembly of complex I and probably stabilizes a 400-
kDa subcomplex that forms the initial nucleus of the peripheral
arm and its juncture with the membrane arm.
Mammalian complex I (NADH:ubiquinone oxidoreductase)
is an L-shaped protein complex of 44 subunits with a combined
molecular mass of 1 MDa bound in the inner membranes of
mitochondria (1–3). One arm of the complex extends into the
matrix of the organelle, and the orthogonal arm is bound in the
inner membrane (4). The extrinsic arm contains the binding
sites for NADH and the primary electron acceptor, FMN, and
also a chain of seven iron-sulfur clusters that carries the elec-
trons to the terminal acceptor, coenzymeQ. The oxidized form
of coenzyme Q binds in the region of the juncture between the
extrinsic and membrane arms (5, 6). Once reduced, it is
released into the reduced quinone pool from where it carries
the electrons to the cytochrome bc1 complex. The transfer of
each two electrons through complex I is coupled to the extru-
sion of four protons from the mitochondrial matrix into the
intermembrane space (7, 8), probably via four antiporter folds
in the membrane domain (6). Thus, complex I contributes to
the generation of the transmembrane proton motive force,
which is itself coupled energetically to ATP synthesis, metabo-
lite transport, and other activities. Seven hydrophobic subunits,
known as ND1–ND6 andND4L, in themembrane arm that are
encoded in mitochondrial DNA and seven of the nuclear
encoded subunits in the peripheral arm together form the cat-
alytic core of the enzyme. This catalytic core is conserved in
complexes I in eukaryotes and eubacteria (9, 10). The remain-
ing subunits are distributed between peripheral andmembrane
arms and do not evidently participate in the known catalytic
activities of complex I. They are known collectively as the
“supernumerary” subunits (9, 11). Some of them may have a
role in the assembly of complex I (12–15).
Specific human pathogenic mutations have been mapped to
all of the core subunits of complex I and currently to 10 of the
supernumerary subunits (16–19). Frequently, they interfere
with the assembly of complex I leading to deficiency of the
active enzyme and often to the accumulation of subcomplexes
of the enzyme that represent stalled intermediates in the path-
way of assembly (16). The partial characterization of these sub-
complexes provides the basis of a model for the assembly pro-
cess in which two distinct preformed subassemblies are joined
together to provide the initial junction between the membrane
andmatrix arms. This intermediate complex is expanded by the
addition of the distal region of the membrane arm, a domain
containing the NADH and FMN binding sites to the distal
region of the matrix arm, and the remaining supernumerary
subunits (16). This assembly process depends upon the partic-
ipation of at least 12 exogenous protein factors that are not
constituents of the mature functional enzyme. Six of them,
NDUFAF1–4, ACAD9, and ECSIT, bind specifically to various
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subcomplexes in the assembly pathway (20–25), but their
molecular functions and the roles of the six other factors
NDUFAF5–7, FOXRED1, NUBPL, and TMEM126B (26–31)
in complex I assembly are not known. Pathogenic humanmuta-
tions have been mapped to NDUFAF1–4, ACAD9, FOXRED1,
andNUBPL (20, 23, 25, 29, 32, 33). NUBPLmay be required for
the process of incorporation of iron-sulfur clusters into sub-
units of complex I (28). NDUFAF5 and 6 appear to stabilize by
unknownmechanisms the initial nucleating subcomplex of the
matrix arm that interacts with themembrane subunit ND1 (34,
35). Mutations in NDUFAF5 and 6, or suppression of expres-
sion ofNDUFAF7, affect its assembly and impair its activity (26,
27, 30). NDUFAF6 could be a phytoene synthase involved in
biosynthesis of carotenoids, and NDUFAF5 and NDUFAF7 are
predicted to belong to the family of S-adenosylmethionine-de-
pendent methyltransferases characterized by the presence in
their structures of a 7-strand protein fold (36). It has been
suggested from indirect evidence obtained in Dictyostelium
that MidA, the orthologue of NDUFAF7, might be a protein
methylase, and mutation of specific conserved residues that
have been associated with the enzymic mechanism of meth-
ylases supported this suggestion (30). These residues are con-
served in the human orthologue. Based on yeast two-hybrid
screens, evidence was provided thatDictyosteliumMidA inter-
acts with the NDUFS2 (49 kDa) subunit of Dictyostelium com-
plex I. Moreover, on the basis of proteomic studies conducted
in rat that proposed that Arg-290 of the NDUFS2 subunit is
monomethylated, it was suggested that the orthologous residue
in human subunit NDUFS2might be the residuemethylated by
human NDUFAF7 (30). However, there was no direct evidence
from these earlier studies that human NDUFAF7 is a protein
methylase or that it modifies by methylation any subunit of
human complex I, including the NDUFS2 subunit. It is now
known that Arg-290 is not methylated in either bovine or
human mitochondria (37).
As reported below, we have confirmed a previous observa-
tion (30) that NDUFAF7 is targeted to human mitochondria.
We have established that it is a protein methylase and that it is
responsible for the methylation of residue Arg-85 in the
NDUFS2 subunit of complex I. We have shown recently that
this residue carries two methyl groups attached symmetrically
to the -NG- and -NG-nitrogen atoms of its guanidino group
(37).
EXPERIMENTAL PROCEDURES
Bioinformatic Analyses—The 66 known and 142 putative
humanmethyltransferases (36)were examined for the presence
of N-terminal mitochondrial targeting sequences with the pro-
grams MitoProt, iPSORT, and TargetP (38–40).
Cell Culture—Human143Bosteosarcoma cells (ATCCnum-
berCRL8303) were grown at 37 °C inDMEMcontaining 25mM
glucose and supplemented with FBS (10% v/v), penicillin (100
units/ml), and streptomycin (0.1 mg/ml) under an atmosphere
of 5% CO2.
Determination of the Subcellular Location of NDUFAF7—
The cDNA for human NDUFAF7 (Fisher) was amplified with
the forward and reverse primers 5-GCCTGATCAGGAAT-
GAGTGTACTGCTGAGGTCAG-3 and 5-ACCGCTCGA-
GCTGCCAAGCAAGTTCACTAAAC-3, respectively, enco-
ding FLAG and Strep II tags at the C terminus of the protein,
and cloned into plasmid pcDNATM5/FRT/TO (Invitrogen).
The plasmid DNA was transfected into 143B cells with Lipo-
fectamine 2000 (Invitrogen). After 24 h, themitochondria were
labeled with 200 nM MitoTracker Orange (Invitrogen) and nu-
clei withDAPI stain (0.4g/ml). The same cells were fixedwith
4% (w/v) paraformaldehyde and permeabilized with Triton
X-100 (0.5% v/v). The FLAG-tagged proteins were detected
withmouseM2 anti-FLAG antibody (Sigma) followed by Alexa
Fluor 488 goat anti-mouse secondary antibody (Invitrogen).
The fluorescent signal was visualized with a Zeiss 510 LSM
confocal microscope.
Suppression of Expression of Subunits of Complex I—Tran-
scripts for NDUFAF7 were suppressed transiently in human
143B osteosarcoma cells with 30 nM siRNA (MISSION siRNA;
Sigma). Three successive transfections were performed at 72-h
intervals. A negative control siRNA (Allstars negative control
siRNA;Qiagen) was used at the same concentration. Reduction
of transcripts for NDUFAF7 was assessed by quantitative real
time PCR performed with a TaqMan gene expression assay
(Invitrogen), on cDNA prepared with a Cells-to-CT kit
(Invitrogen). The levels of the transcripts for NDUFAF7
(normalized to endogenous -actin) were investigated, and
samples enriched for mitoplasts or inner mitochondrial
membrane proteins were prepared 48 h after each transfec-
tion. The phenotype of cells was assessed 48 h after the sec-
ond and third transfections.
Measurement of Respiration—The impact of the suppression
of expression of NDUFAF7 on the OCR3 by human osteosar-
coma 143B cells was measured in an XF24 extracellular flux
analyzer (Seahorse Biosciences, North Billerica, MA) 48 h after
the second and third transfectionswith siRNAat 120 and 192 h.
The assay medium consisted of DMEM base formulation
(Sigma) plusNaCl (1.85 g/liter), 2mMglucose, 2mMGlutaMAX
(Invitrogen), 1 mM pyruvate, phenol red (15 mg/liter), and 20
mM HEPES (pH 7.4). Cells in assay medium were equilibrated
for 1 h at 37 °C in air. Then basal OCRwasmeasured and either
2-deoxyglucose (20 mM), rotenone (600 nM), duroquinol (627
M), and antimycin (600 nM), or 2-deoxyglucose (20 mM), olig-
omycin (100 nM), carbonylcyanide p-(trifluoromethoxy)phe-
nylhydrazone (500 nM), and a combination of rotenone (600
nM) and antimycin A (600 nM), were added sequentially. Com-
plex I-dependent OCR was corrected for nonmitochondrial
oxygen consumption by subtraction of rotenone-inhibited
OCR values from values obtained after the addition of 2-deoxy-
glucose; complex III-dependentOCRwas corrected for nonmi-
tochondrial oxygen consumption by subtraction of antimycin
A-inhibitedOCR values from values obtained after the addition
of duroquinol. Respiration was normalized to cell number by
the sulforhodamine B colorimetric assay (41). p values for the
OCR were calculated with a paired Student’s t test.
Protein Analyses—Cells were suspended at a protein concen-
tration of 10 mg/ml in PBS with complete EDTA-free mix of
protease inhibitor (Roche Applied Science) and enriched for
3 The abbreviations used are: OCR, rate of consumption of oxygen; CID, colli-
sion-induced dissociation; Cam, carbamidomethylcysteine.
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mitoplasts by addition of an equal volume of digitonin (1
mg/ml) in PBS inhibitor, to give a detergent:protein ratio of 1:10
(w/w) (42). The sample was centrifuged (11,000  g, 5 min,
4 °C), and crude mitoplasts were solubilized from the pellet
with 1% (w/v) n-dodecyl -D-maltoside. Samples enriched for
inner mitochondrial membrane proteins were prepared by
using a higher concentration of digitonin (4 mg/ml). Proteins
were fractionated by SDS-PAGE on Novex Tris-glycine 10–20%
acrylamide gradient gels (Invitrogen) and transferred electro-
phoretically from gels to an Immobilon P membrane (Milli-
pore, Billerica, MA) at 300 mA for 60 min in chilled buffer
consisting of 10mM sodium bicarbonate, 3mM sodium carbon-
ate, and 0.025% (w/v) SDS. The membrane was washed in PBS
containing 0.01% (v/v) Tween 20 (PBST) and then blockedwith
a solution of dried skimmed milk in PBST. The treated mem-
brane was incubated with primary antibodies and then with
a goat anti-rabbit (Fisher Scientific) or rabbit anti-chicken
(Sigma) peroxidase-conjugated secondary antibody. The anti-
body incubations were performed inmilk-PBST. Primary rabbit
antibodies against the complex I subunits NDUFS2 andNDUFS7
were obtained fromAbcam (Cambridge, UK), and the rabbit anti-
citrate synthase antibody was purchased from Proteintech (Man-
chester,UK).Aprimary chicken antibody against thehumanND1
peptideAETNRTPFDLAEGEwas producedbyAgrisera (Vannas,
Sweden). Bound antibodies were detected by chemiluminescence
using ECL prime reagents (GEHealthcare).
To assess the impact of suppressionof expressionofNDUFAF7
on the assembly of complex I, samples enriched for inner mito-
chondrial membrane proteins were analyzed by blue native
PAGE in bis-Tris 3–12% acrylamide gradient gels (Invitrogen;
75 V for 1 h and 150 V for 2 h at 4 °C). Fractionated proteins
were transferred electrophoretically in transfer buffer lacking
SDS to an Immobilon P membrane, as described above. Mem-
branes were probed with antibodies against subunits NDUFB8
(Sigma), NDUFS2 of complex I, and the SDHB subunit of com-
plex II (Sigma).
Mass Spectrometric Analysis—The effect of the suppression
of expression of NDUFAF7 on the methylation status of
NDUFS2was studied by analyzing the two tryptic peptides (res-
idues 75–89 and 76–89) containing the methylated arginine
85. Crude mitoplast proteins were reduced with 5 mM Tris
(2-carboxyethyl)-phosphine, pH 7.0, alkylated with 15 mM
iodoacetamide in SDS gel sample buffer at pH 8.0, and fraction-
ated on Novex Tris-glycine 10–20% (Invitrogen) acrylamide
gradient gels. Proteins were identified by tryptic mass mapping
of Coomassie Blue-stained bands or sections of gel (43) in a
MALDI-TOF-TOFmass spectrometer (model 4800; AB-Sciex,
Warrington, UK) with -cyano-4-hydroxycinnamic acid as
matrix. CIDwas performedwith air. Peptideswere fractionated
also by reverse phase nanochromatography with a Proxeon
Easy-nLC instrument (Thermo Fisher, Hemel Hempstead,
UK). The C18 column (75-m inner diameter  100 mm;
Nanoseparations, Nieuwkoop, The Netherlands) was eluted
with an acetonitrile gradient in 0.1% (v/v) formic acid at 250
nl/min and was coupled directly to an LTQOrbiTrap XL-ETD
(electron transfer dissociation) mass spectrometer (Thermo
Fisher). Peptides were fragmented by CID with nitrogen. Pro-
teinswere identified frompeptidemass and fragmentationdataby
interrogation of NCBInr protein sequence databases with Pro-
teome Discoverer 1.3 (Thermo Fisher) and the Mascot search
engine (44).Therelativeabundanceof twomethylated trypticpep-
tides (residues 76–89 and 75–89 of subunit NDUFS2; Cam-
DPHIGLLHRGTEK and KCamDPHIGLLHRGTEK), plus one
nonmethylated version (residues 75–85, KCamDPHIGLLHR)
found only in cells where expression of NDUFAF7 had been sup-
pressed, were estimated from the peak areas of Gaussian
smoothed extracted ion chromatograms obtained with Xcalibur
(Thermo Fisher) using anm/z tolerance of 5 ppm. Monoisotopic
m/z values used are 830.9336 (M 2H)2, 554.2916 (M 3H)3,
and 894.9810 (M  2H)2, 596.9899 (M  3H)3 for the two
methylated peptides, respectively, and 673.3620 (M 2H)2 and
449.2439 (M  3H)3 for the nonmethylated peptide. The two
methylated tryptic peptides were identified by Proteome Discov-
erer from the fragmentation spectrum produced by CID. To aid
the identification of the unmethylated peptide representing resi-
dues 75–85 of subunit NDUFS2, a synthetic versionwas obtained
fromCambridge Research Biochemicals (Billingham, UK).
RESULTS
Bioinformatic Identification of Putative Methyltransferases
inMitochondria—From among the 66 known and 142 putative
human methyltransferases, 33 were predicted to have mito-
chondrial targeting sequences, including 23 representatives of
the 7-strand family ofmethyltransferases, fivemembers of the
family characterized by the presence of a SET domain, three
spout methyltransferases, and two radical S-adenosylmethio-
nine methylases (Table 1). Two additional proteins, NSUN3
and TRMT11, although not predicted to have processed N-ter-
minal targeting sequences, nonetheless are known to be mito-
chondrial proteins (45). This analysis did not distinguish
between protein and RNA methyltransferases. From among
these 35 proteins, and taking into consideration the earlier
work on MidA (30), NDUFAF7 was selected for study. Confir-
mation of its location inmitochondria was obtained by express-
ing the protein with a C-terminal FLAG tag in human osteosar-
coma 143B cells and then by visualizing the protein with the aid
of an antibody directed against the FLAG tag. Its location in the
cells was coincident with mitochondria (Fig. 1) in confirmation
of the bioinformatic prediction and of earlier observations (30).
Effect of Suppression of Mitochondrial NDUFAF7 on the
Function of Complex I—Transient suppression of expression of
NDUFAF7 in human 143B cells decreased the level of tran-
scripts for NDUFAF7 to 30% of the control (normalized to
endogenous -actin), and this level of suppression was main-
tained over the course of the experiment (Fig. 2). Associated
with the suppression of expression of NDUFAF7, the cellular
OCR linked to complex I was reduced by more than half after
120 h (Fig. 3A) and bymore than 90% after 192 h (Fig. 3B). After
120 h, the reduction in OCR was confined mainly to complex I
(Fig. 3A), but later, at 192 h, the effect on the OCR was more
general, as shown by the large decreases in OCR linked to com-
plex III and the E/L ratio (Fig. 3B; the E/L ratio is defined in the
legend to Fig. 3). These experiments together with the bioinfor-
matics analysis suggested that NDUFAF7 might be a protein
methylase that modifies one of the subunits of complex I.
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Effect of Suppression of Expression of NDUFAF7 on theMeth-
ylation of NDUFS2—Because Arg-85 in the NDUFS2 subunit
of human complex I is dimethylated symmetrically and
completely (37), the effect of suppression of expression of
NDUFAF7 on the methylation status of this residue was inves-
tigated. In the tryptic digests ofmitoplast proteins from control
cells, the region of sequence of NDUFS2 containingArg-85was
represented by two overlapping peptides, residues 75–89 and
TABLE 1
Humanmitochondrial methyltransferases
The table includes known mitochondrial methyltransferases and others identified by bioinformatic analysis. No attempt was made in the bioinformatic analysis to
differentiate protein and RNA methyltransferases. The sequences of 66 methyltransferases of known function, and 142 putative methyltransferases of unknown function
(36) were analyzed with MitoProt, iPSORT, and TargetP for the presence of N-terminal mitochondrial targeting sequences. Mitoprot scores of0.5 indicate the presence
of a targeting sequence. The family classification is taken from Ref. 36. The families of methyltransferases are as follows: 7, 7-strand; SET, SET domain (Drosophila
Su(var)3–9, Enhancer of zeste and Trithorax); Spout, SpoU and TrmD methyltransferases; rad-Sam, radical S-adenosylmethionine. Cyt gra, cytoplasmic granules; ER,
endoplasmic reticulum; hMito and yMito, human and yeast mitochondria; Mem, membranes.
Protein
Algorithm
Family Function LocationMitoProt iPSORT TargetP
ASMTL 0.58   7 No Unknown
C3orf51 0.88   7 No Unknown
COQ3a 0.99   7 Yes (54) hMito (45)
COQ5a 0.97   7 Yes (55) hMito (45)
FTSJ2b 0.48   7 No (66) Nucleus (66)
METTL7A 0.83   7 No ER, Mem (67, 68)
METTL8 0.79   7 No hMito (45)
METTL9 0.99   7 No Unknown
METTL12 0.96 -  7 No Unknown
METTL15 0.70  ? 7 No hMito (45)
METTL17c 0.82   7 No (69) hMito (26)
METTL20 0.77   7 No Cyt gra (70)
NDUFAF5 0.99   7 No hMito (27)
NDUFAF7 0.96   7 No hMito (30)
NSUN3 0.12  ? 7 No hMito (45)
NSUN4d 0.69   7 No (71) hMito (71)
PRMT8 0.73   7 Yes (72) Mem (72)
RRNAD1 0.58   7 No Unknown
TFB1Me 0.86   7 Yes (73) hMito (73)
TFB2Me 0.67   7 Yes (74) hMito (74)
TRMT1f 0.91   7 Yes (75) Unknown
TRMT2B 0.92   7 No hMito (26)
TRMT5g 0.66   7 Yes (76) Unknown
TRMT11 0.31   7 No hMito (45)
TRMT61B 0.74   7 Yes (77) hMito (45, 77)
EZHIh 0.46  ? SET Yes (78) Nucleus (78)
MLLh 0.78  ? SET Yes (79) Nucleus (80)
SETD9 0.99   SET No hMito (45)
WBP7h,i 0.64  ? SET No (81) Unknown
ZFPM1 0.99   SET No Unknown
MRM1j 0.99   Spout No (82) yMito (82)
RG9MTD1k 0.99   Spout Yes (83) hMito (83)
RNMTL1 0.93   Spout No hMito (26, 45)
CDK5RAP1 0.60   rad-SAM No Unknown
RSAD1 0.90   rad-SAM No Unknown
a Required for ubiquinone synthesis.
b rRNA methyltransferase in yeast.
cMay be a component of the mitochondrial small ribosomal subunit.
d In the mitochondrial ribosome; forms a complex with MTERF4.




iMethyltransferase activity observed in mouse.
jMethylates yeast mitochondrial 21 S rRNA.
kMitochondrial tRNA maturation.
FIGURE1.Subcellular locationofNDUFAF7.Human143Bosteosarcomacellswere transfectedwithplasmidpcDNATM5/FRT/TOcontaining thecoding region
for NDUFAF7 with C-terminal StrepII and FLAG tags and immunocytochemistry performed 24 h later. A, nucleus stained with DAPI (blue). B, recombinant
NDUFAF7 visualized with anti-FLAG antibody and goat anti-mouse Alexa Fluor 488 (green). C, mitochondria stained with Mitotracker (red). D, A–Cmerged.
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76–89, in which Arg-85 remained fully dimethylated (Fig. 4).
As found previously (37), therewas no evidence of tryptic cleav-
age of the amide linkage between residues Arg-85 and Gly-86,
as would be expected if this Arg-85 is fully dimethylated, and
there was no evidence ofmonomethylated Arg-85. However, in
the tryptic digests of the samples produced by transient sup-
pression of expression of NDUFAF7, from 48 h, there was a
progressive shift from dimethylated to nonmethylated status.
At 120 h, only 40%of the peptidewas dimethylated, and at 192 h
the level of dimethylation had decreased further to 15%. Con-
comitant with these changes, increasing amounts of the
unmethylated peptide (residues 75–85), arising from tryptic
cleavage following the unmethylated Arg-85, were observed
over the course of the experiment (26.9, 60, and 85%, respec-
tively, at 48, 120, and 192 h; Fig. 4A). The identification of the
unmethylated peptide by tandemMSwas aided by comparison
with the spectrum of a synthetic version of the same peptide
(Fig. 4, B and C). The dominant ions in the CID spectra are
common to both samples, arising from predominant cleavage
at the Asp-Pro bond (b3 and y8 ions). The origin of the addi-
tional fragment ions in the magnified portion of the spectrum
from the mitoplast sample (Fig. 4B, inset) is unknown, but they
are likely to arise from minor contaminating tryptic peptides.
Hence, suppression of expression of NDUFAF7 is accompa-
nied by suppression of dimethylation of Arg-85 of NDUFS2.
Therefore, NDUFAF7 is a protein methylase that modifies res-
idue Arg-85 of subunit NDUFS2 of complex I producing a sym-
metrically dimethylated guanidino group.
Effect of Suppression of NDUFAF7 on the Assembly of Com-
plex I—To examine whether the suppression of methylation of
Arg-85 affected the assembly of complex I in human 143B cells,
respiratory complexes were fractionated by SDS-PAGE and
blue native PAGE, and the integrity of complex I was examined
byWestern blotting. As shown in Fig. 5A, the level of NDUFS2
was unchanged over the course of the experiment. In contrast,
NDUFS7, another peripheral arm subunit of complex I, and
ND1, amitochondrially encoded subunit in themembrane arm
of complex I, were both lost progressively in NDUFAF7-de-
pleted cells compared with control cells. This observation sug-
gested that suppression of the methylation of NDUFS2 was
influencing the assembly of complex I. This suggestion was
confirmedby examination of complex I in cells inwhich expres-
sion of NDUFAF7 was suppressed where it was found that the
level of intact complex I was reduced significantly relative to
control cells (Fig. 5B). This reduction of intact complex I was
accompanied by the accumulation of a subcomplex with an
apparent molecular mass of 460 kDa, containing subunit
NDUFB8, a component of themembrane armof complex I, and
by the loss of a subcomplex with an apparentmolecularmass of
400 kDa containing subunit NDUFS2, a component of the
peripheral arm of the enzyme.
DISCUSSION
Methylation of Proteins in Mitochondria—The N-methyla-
tion of proteins involves the enzymic addition ofmethyl groups
FIGURE 2. Transient suppression of expression of NDUFAF7 in human
143Bcells. The cellswere transfected three times at 72-h intervalswith either
siRNA directed against transcripts for NDUFAF7, or with control siRNA. The
suppression of the transcript for NDUFAF7 was examined 48 h after each
transfection (normalized to endogenous -actin). The hatched andwhite his-
tograms represent the levels of transcripts for NDUFAF7 and the control (ctr),
respectively, and error bars show the standard deviation.
FIGURE 3. Effect of transient suppression of expression of NDUFAF7 on
oxygen consumption by human 143B cells. Expression of NDUFAF7 was
suppressed three times with siRNA at 72-h intervals and compared with the
effect of control siRNA. The OCR at 120 and 192 h after the first transfection,
normalized to cell number, was measured after the successive additions of
2-deoxyglucose, rotenone, duroquinol, and antimycin or 2-deoxyglucose,
oligomycin, carbonylcyanide p-(trifluoromethoxy)phenylhydrazone, and a
combination of rotenone and antimycin A. The E/L ratio (the carbonylcyanide
p-(trifluoromethoxy)phenylhydrazone/oligomycin ratio) is an index of the
maximumoxygen consumption capacity of the electron transport system (E)
relative to themagnitude of the noncoupled respiration (L). A and B show the
effect of suppression of expression of NDUFAF7 at 120 and 192 h, respec-
tively. The shaded and white bars correspond to cells treated with siRNA
against NDUFAF7 and control cells, respectively.
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donated by S-adenosylmethionine to the side chain nitrogen
atoms of lysine and arginine, or more unusually to the imidaz-
ole side chain of histidine residues or to the -N atom of the
protein. Up to threemethyl groups can be added to the -amino
groupof lysine, andthemodifiedarginines,-NG-monomethyl-
arginine, asymmetric-NG,NG-dimethylarginine and symmet-
ric -NG,NG-dimethylarginine, have all been observed. More
and more mammalian proteins are being found to be methy-
lated (46–48), and, among others, protein methylation has
roles in regulating signal transduction, transcription, RNA
processing, translation,DNArepair, protein translocation, pro-
tein interactions, and protein dynamics (46, 49, 50). Because
lysine side chains can be modified also by acetylation and ubiq-
uitination, the interplay between different modifications at the
same site and adjacent sites can influence the functions of the
proteins. Moreover, the actions of protein methylases and de-
methylases at the same site provide additional complexity in the
role thatmethylation plays in the regulation of cellular activities
(51–53). In the current work, 33 putative and known methyl-
transferases (22 putative, 11 known), including NDUFAF7,
were identified by bioinformatic analysis as having the charac-
teristics of proteins that are imported into mitochondria, plus
NSUN3 andTRMT11, that are bona fidemitochondrial protein
methylases (45). This list contains seven known RNA methyl-
ases because no attempt was made to distinguish between pro-
tein and RNA methylases (Table 1) and two proteins that par-
ticipate in the biosynthesis of ubiquinone (54, 55). So far no
protein demethylase has been identified inmitochondria either
experimentally or by bioinformatics.
A small subset of proteins in mammalian mitochondria is
known to be trimethylated completely and stably on the -a-
mino group of specific lysine residues. They are citrate syn-
thase, ADP-ATP translocase, and the c-subunit of ATP syn-
thase, but the biological significance of these modifications
remains unknown (56–58). Moreover, the mutation of yeast
methyltransferase Ctm1p (59), the cytosolic enzyme responsi-
ble for modifying cytochrome c, had no impact on either the
activity of cytochrome c or cell viability (60), andmethylation is
not essential for the activity of pig citrate synthase (61). In addi-
tion, two subunits of respiratory complex I are modified post-
FIGURE 4.Mass spectrometric analysis of the effect of suppression of expression ofNDUFAF7on themethylation status of Arg-85 in subunit NDUFS2
of complex I. The 143B cells were transfected three times at 72-h intervals, with control siRNA, or with NDUFAF7 specific siRNA. The methylation status of
tryptic peptides containing Arg-85 was examined by mass spectrometric analysis of tryptic digests of mitoplasts prepared from control and suppressed cells
at 48, 120, and 192 h after the first transfection. In A, the histograms are derived from the extracted ion chromatograms for the m/z values of all possible
methylation states for tryptic peptides containingArg-85. Histograms labeleda andb correspond to control and suppressed cells, respectively.Black andwhite
areas correspond to dimethylated and nonmethylated Arg-85, respectively. B and C, CID fragmentation spectra of, respectively, the tryptic peptide (residues
75–85 of NDUFS2) containing unmethylated Arg-85 derived frommitoplasts from cells where expression of NDUFAF7 has been suppressed and of a synthetic
peptidewith the same sequenceKCamDPHIGLLHR. The inset spectra showamagnified y axis view from500 to900m/z. In the inset inB,Edenotes the ionsb92
(517.97), y4 (538.46), b102 (586.57), and b6 (751.52) of the nonmethylated NDUFS2 peptide. The origin of the additional minor ions (●) is unknown. The
sequence inset shows the fragment ions mapped onto the amino acid sequence.
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translationally bymethylation: theNDUFB3 subunit has a com-
plex pattern of methylation on three histidine residues near its
N terminus (62), and Arg-85 of subunit NDUFS2, the subject of
the current investigation, is symmetrically dimethylated (37).
In proteomic studies of mitochondria of trypanosomes, 167
proteins have been reported to be methylated (63), but in pro-
teomic studies of methylated sites in mammalian cells, many
fewer have been detected so far. In addition to the five men-
tioned already, only kynurenine-oxoglutarate transaminase 3,
DNA-directed RNA polymerase, 60-kDa heat shock protein,
serine-pyruvate aminotransferase, carbamoyl-phosphate syn-
thase, prohibitin, hydroxymethylglutaryl-CoA synthase, poly-
ribonucleotide nucleotidyltransferase 1, and 39 S ribosomal
protein L35 are reported to bemethylated (46–48) and present
in both the MitoCarta and IMPI mitochondrial protein data-
bases (26, 64). Among them, only kynurenine-oxoglutarate
transaminase 3 is methylated on an arginine residue; the rest
contain methylated lysine residues.
Role of NDUFAF7 as a Protein Methylase That Modifies
Complex I—Until the present work, nomethylase thatmodifies
a protein in mammalian mitochondria had been identified
unambiguously. In the experiments described above, it has
been confirmed that NDUFAF7 localizes to the mitochondria
of human 143B cells and that suppression of its expression has
no influence on the level of NDUFS2, but that the methylation
status of Arg-85 is progressively reduced with time, down to
15% after 192 h of suppression of expression. These experi-
ments establish that NDUFAF7 is the enzyme in mitochondria
that is responsible for the symmetrical dimethylation of Arg-85
of the NDUFS2 subunit of complex I, either during emergence
into the mitochondrial matrix from the TIM complex involved
in the import process and found in the inner membrane or
following the release of the mature protein from the TIM com-
plex into the matrix space. Protein arginine methyltransferases
have been placed into three classes known as types I–III. All
three types are associated with the formation of -NG-mono-
methylarginine, and the type I enzymes convert it to asymmet-
ric -NG,NG-dimethylarginine. Only the type II enzymes pro-
duce symmetrical -NG,NG-dimethylarginine, and there was
no evidence for the formation of intermediate monomethy-
larginine in the current experiments. Therefore, NDUFAF7
belongs to type II of the argininemethyltransferases. The inter-
action of NDUFAF7 with NDUFS2 appears to be transient
because no stable complex involving the two proteins was
detected by examination of possible protein associations
between the two proteins (data not shown).
Role of NDUFAF7 in the Assembly of Complex I—The reduc-
tion in the activity of complex I (Fig. 3) and the loss of subunits
NDUFS7 and ND1, both effects being concomitant with the
suppression of expression of NDUFAF7, provided direct evi-
dence that the methylation of Arg-85 in subunit NDUFS2 was
required for the assembly of active complex I. The effect of
partially blocking this methylation reaction on the integrity of
the complex was evident from the analysis of complex I and
related subcomplexes by blue native PAGE (Fig. 5). This analy-
sis showed a reduction in the level of fully assembled complex I
and of a related 400-kDa complex and concomitantly the accu-
mulation of a 460-kDa subcomplex of complex I. Both the 400-
and 460-kDa subcomplexes have been identified previously as
intermediates in the pathway of assembly of complex I (Fig. 6).
The 400-kDa subcomplex is an early assembly intermediate
that, in addition to NDUFS2, contains the core catalytic sub-
units NDUFS3, NDUFS7, and NDUFS8 and the membrane
subunit ND1 (16, 24). This subcomplex is thought to provide
the membrane-proximal portion of the peripheral arm and the
adjoining region of themembrane arm. In addition toNDUFS2,
the membrane-proximal part of the peripheral arm contains
subunit NDUFS7 and the covalently associated 4Fe-4S cluster,
N2. Thus, it appears that themethylation of Arg-85 inNDUFS2
is required for the formation of the 400-kDa assembly interme-
diate. In the absence of the methylation, the subcomplex is not
formed, andNDUFS7 andND1 protein levels are depleted (Fig.
6), probably by the rapid turnover of newly synthesized pro-
teins, similar to the effects of suppressing other assembly fac-
tors (NDUFAF3–6) involved in the formation of the 400-kDa
intermediate (35). However, the levels of transcripts for ND1,
NDUFS2, and NDUFS7 were unchanged by suppression of
expression of NDUFAF7 (data not shown). NDUFAF5, another
complex I assembly factor and a putative methyltransferase, is
also required for the stable formation of the initial peripheral
arm subcomplex (27, 35). Although suppression of expression
of NDUFAF5 disrupted the assembly of the 400-kDa interme-
diate, there was no associated change in the methylation status
of NDUFS2 (data not shown). Pathogenic mutations are asso-
FIGURE 5. Effect of transient suppression of expression of NDUFAF7 on
the assembly of complex I. Samples were prepared at the times indicated
from human 143B cells that had been transfected three times with either
control siRNA or siRNA specific for NDUFAF7 at 72-h intervals. In A and B,
control and suppressed samples are denoted by a and b, respectively. A, the
mitoplasts were fractionated by SDS-PAGE, blotted, and detected with anti-
bodies against subunits NDUFS2, NDUFS7, and ND1 of complex I and with
citrate synthase (CS) as a loading control. B, inner mitochondrial membrane
proteins were fractionated by blue native PAGE, blotted, and detected with
antibodies against NDUFB8 and NDUFS2, subunits in the membrane and
peripheral arms of complex I, respectively, with an antibody against complex
II as loading control.
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ciated with NDUFAF5, and also with many, but not all, of the
proteins that assist in the assembly of complex (20, 23, 25, 29,
32, 33). So far, none has been found to be associated with
NDUFAF7. Because NDUFAF7 acts early in the pathway of
assembly of complex I, human mutations affecting its function
may be lethal.
It is possible that the methylation of Arg-85 in the NDUFS2
subunit of complex I plays a role not only in the assembly of the
complex, but also in themechanismof the enzyme. In the struc-
ture of complex I from Thermus thermophilus, the orthologues
of human subunits NDUFS2 and NDUFS7, together with sub-
unit ND1, provide the binding pocket for ubiquinone (6), and it
is most likely that the human orthologues have a similar dispo-
sition (Fig. 7) and also provide the binding site for the quinone.
SubunitNDUFS7 contains covalently bound iron-sulfur cluster
N2, which is the terminal iron-sulfur cluster in the chain of
seven iron-sulfur clusters linking a noncovalently bound FMN
molecule, the primary acceptor of electrons fromNADH, to the
terminal electron acceptor, ubiquinone. In this model, methyl-
atedArg-85 of subunit NDUFS2 by analogy with the position of
the orthologous threonine residue 64 in the structure of com-
plex I from T. thermophilus is 7 Å (or possibly even closer)
from iron-sulfur cluster N2 (Fig. 7). Themethylation of the side
chain of this residue has a number of effects. It increases its
hydrophobicity and the solvent-accessible area of the side
chain, and reduces its potential to form hydrogen bonds.Meth-
ylation also lowers its pI value slightly, and so it might conceiv-
ably influence the redox potential of cluster N2. The evaluation
of this possibility must probably await an atomic structure of
mammalian complex I.
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